ACCC association of cancer care centers
Join/Renew
Login
Join/Renew
Login
Education & Resources
ACCC eXchange LogInCorporate Member Sponsored ResourcesPresentations & AbstractsACCC Connect eLearning LogIn
Publications
Oncology IssuesPatient Assistance & Reimbursement GuideTrending Now in Cancer CareBusiness Case Studies for Hiring New Staff
Events
2026 ACCC Leadership SummitAnnual Meeting & Cancer Center Business SummitCapitol Hill DayNational Oncology ConferenceOncology Reimbursement MeetingsOncology State Society Meetings
Policy & Advocacy
ACCC 2026 Policy PrioritiesLetters & StatementsAccess, Payment & Reimbursement ReformWhite Bagging & Brown BaggingAdvocacy ResourcesCancer Moonshot
Membership
Join | RenewWho We AreMembership Types & BenefitsCorporate MembersACCC Member Portal FAQMember Directory
Partners
Oncology State SocietiesPartner OrganizationsCME
News
News ReleasesAdvocacy News ReleasesOncology News
About ACCC
Timeline / 50th Anniversary2025 Impact ReportPresident's ThemeACCC Innovator AwardsACCC FellowsBoard of TrusteesACCC Senior Staff
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
Join/Renew
Login
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
    • Education & Resources
    • Publications
    • Events
    • Policy & Advocacy
    • Membership
    • Partners
    • News
    • About ACCC
ACCC association of cancer care centers
1801 Research Boulevard, Suite 400, Rockville, MD 20850
Tel: 301.984.9496 Email Us
Contact UsVolunteers
Advertise
Career Center
Terms and Conditions
Privacy Policy
ACCC Rebranding
Copyright © 2026 Association of Cancer Care Centers. All Rights Reserved.
HomeACCCBuzz Blog

#AMCCBS: Recognizing Excellence + Leadership Training

March 6, 2024

Highlights from the final day of the ACCC 50th Annual Meeting & Cancer Center Business Summit (#AMCCBS).

#AMCCBS: Recognizing Excellence + Leadership Training

On Friday, March 1, the Association of Cancer Care Centers (ACCC) concluded its 50th Annual Meeting & Cancer Center Business Summit (#AMCCBS). The day began with the announcement of Nadine J. Barrett, PhD, MA, MS, senior associate dean for Community Engagement and Equity in Research at Wake Forest University School of Medicine and Atrium Health and associate director, Community Outreach and Engagement at Wake Forest Comprehensive Cancer Center and Levine Cancer Institute, as the 2024-2025 ACCC President. “As the incoming ACCC president, I am excited to announce my theme: Reimagining Community Engagement and Equity in Cancer,” Dr. Barrett said. “With this theme, I am encouraging all of us as ACCC to ensure that the work we are doing engages our community’s and puts our patients at the center as we continue to move forward in advancing equity in cancer.”

Following her message, Dr. Barrett acknowledged the 2024 ACCC Award winners. These individuals were recognized for their significant contributions to patient care, the practice of clinical care and research, and the greater oncology community.

Award Presentations

The Clinical Research Award, which recognizes individuals whose research has significantly and positively impacted the oncology patient, family, and/or community was presented to Robert Winn, MD, director, and lipman chair in Oncology, VCU Massey Comprehensive Cancer Center. “Dr. Winn walks the talk, all day, every day, with his commitment to advancing equity. He ensures that we look at our patients and our communities as experts in their own right,” Dr. Barrett said. “I am truly humbled to introduce and welcome up to the stage, my friend, my colleague, and my champion, our champion for the cause, Dr. Robert Winn.”

“I want to thank ACCC for all the work that you do,” Dr. Winn said as he accepted the award. Then he asked the audience an important question: Why the need for change? “It is easy to figure out why folks don’t trust us. They see all these organizations working to eradicate cancer, and they don't feel included in the process,” he said. “If you want to change a system, don’t just do something different, do a different thing.”

Dr. Winn’s words embodied the ethos of Dr. Barrett’s theme: it is difficult to care for a community that experiences medical mistrust. Dr. Winn believes trust is built by creating informed, collaborative partnerships, in which the patient is respected as an equal and expert. “ACCC allows us to do a different thing,” Dr. Winn said. “Our organizations need to have a different type of talk, not about what will be taken, but what will be brought to the table.”

Regarding the issue of trust Dr. Winn argues that the cancer care community has been asking the wrong question. “The question should not be how do we get trust, but how do we as an institution become more trustworthy,” he said Dr. Winn believes trust is especially important in recruiting clinical trial participants. “We have to rethink how we are conducting clinical trials,” he said. “We must recognize blind spots, reflect and figure out how we can do better.”

Dr. Winn reminded a captivated audience that while health care workers discuss medical illiteracy among their patients, they too must be aware of their own community illiteracy that needs to be addressed. “What if we do a different thing by training the next generation [oncology workforce] to not only know about the science of clinical trials, but about the communities they take place in,” he said. “Our organizations need to realize that while we exist, we exist as a group. If we start having a different conversation within our communities, what will be possible?”

“Innovation does not equal impact for all—equally.”

In concluding his address, Dr. Winn shared his optimism for the future of community engagement across the cancer care continuum and left attendees with a call to action. “Let us remember that through grace and humility, there is power. We are much more powerful together than we are separate.”

The David King Community Clinical Scientist Award, which recognizes individuals who have demonstrated leadership in the development, participation, and evaluation of clinical studies and/or active in the development of new screening, risk assessment, treatment, or supportive care programs for patient with cancer was presented to Christa M. Braun-Inglis, DNP, APRN, FNP-BC, AOCNP, nurse practitioner and assistant researcher at the University of Hawaii Cancer Center.

“Thank you to everybody at ACCC, who thought enough of me to receive this award,” Dr. Braun-Inglis said upon accepting the award. Like Dr. Winn, Dr. Braun-Inglis highlighted the importance of engaging the community in clinical research and trials. Further, she wagers that advanced practice providers add value to clinical research team in all aspects of clinical trials. Thus, cancer programs and practices must reassess the lens through which they view clinical research staff.

Improving Leadership

The second keynote address at #AMCCBS was delivered by Katherine A. Meese, PhD, assistant professor, Department of Health Services Administration at the University of Alabama at Birmingham. Dr. Meese shared insights on how leaders can strengthen their workforce by focusing on “the human margin.” According to Dr. Meese, leaders must equip their employees with the tools to navigate independently, for as she puts it, “autonomy without skills is cruelty.” Further, Dr, Meese argues that to maximize productivity, employees must understand the end goal, priorities, and values of their organization. “When they can see the map, they can get to the destination,” she said.

Dr. Meese believes the benefit of clear and open communication cannot be overstated. “According to a Gallup poll, employees are 73% less likely to feel burned out at work when they strongly agree that the leadership of their organization communicates effectively with the rest of the organization,” she said. “Employees are also 2.8 times more likely to be engaged when they speak with their manager regularly about their goals and progress.”

To improve communication at their organizations, Dr. Meese shared these conversations starters leaders can adopt:

  • I work for you, what do you want me to work on?
  • What worries you the most?
  • What do you find most rewarding about your work?
  • What challenges are you currently facing in your work?

With the oncology workforce experiencing an unprecedented level of burnout, having these conversations must become a standard procedure at cancer centers and programs. “Seventy-five percent of healthcare executives were burned out in 2022 compared to 60% in 2018,” Dr. Meese said. “The suicide rate for female physicians is 1.46 times higher and approximately 4,800 years' worth of education and training is lost to physician suicide each year.”

Dr. Meese argues that these figures emphasize the importance of improving the wellbeing of the oncology workforce. “Creating a healthy workforce is not just important for meeting the broader goals of the organization but for improving the health of the community,” she said. “Employees who strongly agree that their employer cares about their overall wellbeing are: 3 times more likely to be engaged, 69% less likely to search for a new job, 71% less likely to report burnout, and 36% more likely to be thriving in their overall lives.” Thus, as the broader cancer care community pushes to consistently innovate, it must ensure that those who make that possible are healthy in mind and body, to carry on the life-changing work they do. Through meetings like #AMCCBS, ACCC hopes to create an environment where that goal remains a priority.

Read more about #AMCCBS with ACCCBuzz's coverage of Wednesday and Thursday's events.

Related Content

Extending Patient-Centered Cancer Care to Transgender and Nonbinary IndividualsACCCBuzz Blog

Extending Patient-Centered Cancer Care to Transgender and Nonbinary Individuals

Gabrielle Stearns

June 30, 2026

Transforming Oncology Authorization Through Clinical and Revenue Cycle CollaborationACCCBuzz Blog

Transforming Oncology Authorization Through Clinical and Revenue Cycle Collaboration

Rachel Radwan

June 29, 2026

Building a Blueprint for Precision Medicine: Lessons from TriHealthACCCBuzz Blog

Building a Blueprint for Precision Medicine: Lessons from TriHealth

June 25, 2026

Exploring a Bispecific Antibody for Relapsed or Refractory Multiple MyelomaACCCBuzz Blog

Exploring a Bispecific Antibody for Relapsed or Refractory Multiple Myeloma

June 22, 2026

15 Years Strong: The NCCN State Oncology Society Forum Annual MeetingACCCBuzz Blog

15 Years Strong: The NCCN State Oncology Society Forum Annual Meeting

Sean T. McCarson, MPA

June 16, 2026

Highlights from Volume 41, Number 3 Oncology IssuesACCCBuzz Blog

Highlights from Volume 41, Number 3 Oncology Issues

Gabrielle Stearns

June 15, 2026

ACCC Roundtable Series to Build a CAR T Multiple Myeloma Referral FrameworkACCCBuzz Blog

ACCC Roundtable Series to Build a CAR T Multiple Myeloma Referral Framework

Gabrielle Stearns

June 11, 2026

Precision Medicine Stewardship: Turning Complexity Into Coordinated Cancer CareACCCBuzz Blog

Precision Medicine Stewardship: Turning Complexity Into Coordinated Cancer Care

June 9, 2026

Upcoming Events

ACCC 43rd National Oncology Conference
Oncology

ACCC 43rd National Oncology Conference

In Person Conference & ConventionOctober 21, 2026 at 8:00 AM MDT450 Summer St, Boston, MA 02210Omni Boston Hotel at the Seaport, Boston
Register Now!
KaSCO 2026 Fellows Dinner
Oncology

KaSCO 2026 Fellows Dinner

In Person Conference & ConventionJuly 16, 2026 at 6:00 PM CDT101 West 22nd Street, Kansas City, MO, USALidia's Kansas City, Kansas City
Register Now!
MSCO 2026 Professional Development Workshop
Oncology

MSCO 2026 Professional Development Workshop

In Person Conference & ConventionJuly 18, 2026 at 3:30 PM CDT5005 Glumack Drive, Minneapolis, MN, USAInterContinental Hotel Minneapolis – St. Paul Airport, Minneapolis
Register Now!
NOS 2026 Dinner at the Las Vegas Best of ASCO
Oncology

NOS 2026 Dinner at the Las Vegas Best of ASCO

In Person Conference & ConventionJuly 24, 2026 at 5:30 PM PDT101 Montelago Blvd, Henderson, NV 89011, USAThe Westin Lake Las Vegas Resort & Spa , Henderson
Register Now!
WSMOS 2026 Dinner at the Seattle Best of ASCO
Oncology

WSMOS 2026 Dinner at the Seattle Best of ASCO

In Person Conference & ConventionJuly 24, 2026 at 5:30 PM PDT1415 5th Ave, Seattle, WA, USAHilton Motif Seattle, Seattle
Register Now!
KYSCO 2026 Tri-State Multi-Disciplinary Cancer Care Summit
Oncology

KYSCO 2026 Tri-State Multi-Disciplinary Cancer Care Summit

In Person Conference & ConventionJuly 25, 2026 at 7:30 AM EDT638 Madison Ave, Covington, Kentucky 41011, USAHotel Covington, Covington
Register Now!
HSCO 2026 August Dinner Symposium
Oncology

HSCO 2026 August Dinner Symposium

In Person Conference & ConventionAugust 12, 2026 at 5:30 PM HST6600 Kalanianaʻole Highway suite 110, Honolulu, HI 96825, USARoy's Restaurants – Hawaii Kai, Honolulu
Register Now!
LOS 2026 Cancer Congress - National Oncology Updates
Oncology

LOS 2026 Cancer Congress - National Oncology Updates

In Person Conference & ConventionAugust 14, 2026 at 11:00 AM CDT859 Convention Center Blvd, New Orleans, LA, USANew Orleans Marriott Warehouse Art District, New Orleans
Register Now!
Advertisement
Advertisement

Trending Now on
ACCCBuzz Blog

Extending Patient-Centered Cancer Care to Transgender and Nonbinary Individuals

Extending Patient-Centered Cancer Care to Transgender and Nonbinary Individuals

In a recent article from Oncology Issues, authors conducted a systematic literature review and found that two main drivers of care disparities exist for transgender and nonbinary individuals with cancer: rigid binary gender frameworks and gaps in mental health care.

Transforming Oncology Authorization Through Clinical and Revenue Cycle Collaboration

Transforming Oncology Authorization Through Clinical and Revenue Cycle Collaboration

2026 ACCC Innovator Award Winner St. Luke's Cancer Institute noticed a significant administrative burden being placed on providers to review medical necessity validation for complex oncology therapies. To address the resulting rise in peer-to-peer requirements, delays in care, and pre-service denials, the team designed and implemented a new Clinical Documentation Integrity Registered Nurse role.

Building a Blueprint for Precision Medicine: Lessons from TriHealth

Building a Blueprint for Precision Medicine: Lessons from TriHealth

ACCC launched its Precision Medicine Stewardship Program to highlight institutions that have successfully built the infrastructure, workflows, and leadership models needed to deliver precision medicine at scale. TriHealth Cancer and Blood Institute in Cincinnati, Ohio, offers a compelling example of what it takes to move from aspiration to execution.

Exploring a Bispecific Antibody for Relapsed or Refractory Multiple Myeloma

Exploring a Bispecific Antibody for Relapsed or Refractory Multiple Myeloma

Although patients with relapsed or refractory multiple myeloma now have more treatment options than ever, their journeys are often complex. As clinicians consider when to introduce newer therapies such as bispecific antibodies, they must account for prior treatments, treatment-related toxicities, and comorbidities that may impact treatment decisions.

View All ACCCBuzz Blogs

Recently Heard on
CANCER BUZZ Podcast

MDS: Low Risk Isn’t No Risk - [Podcast] Ep. 239

Beyond Body Art: Restoring Wholeness Through Paramedical Tattooing - [Podcast] Ep. 238

Bridging Radiation and Oncology in SCLC Care - [Podcast] Ep. 237

Championing Bispecific Antibodies in the VA - [Podcast] Ep. 236

View All Podcasts

Latest from Oncology Issues

June 2026
June 2026
April 2026
February 2026
December 2025
October 2025
View All Oncology Issues

Join the Conversation

ACCC eXchange Digital Banner
Login